SEI Investments’s Rigel Pharmaceuticals RIGL Stock Holding History

SEI Investments’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$816K	Buy	30,192 +3,399	+13%	+$114K	﹤0.01%	2448
2025 Q4	$1.15M	Sell	26,793 -33,216	-55%	-$1.25M	﹤0.01%	2125
2025 Q3	$1.7M	Buy	+60,009	New	+$1.8M	﹤0.01%	1767
2025 Q2	–	Sell	-10,302	Closed	-$185K	–	2895
2025 Q1	$185K	Buy	+10,302	New	+$209K	﹤0.01%	2483
2020 Q4	–	Sell	-6,151	Closed	-$148K	–	2523
2020 Q3	$148K	Hold	6,151	–	–	﹤0.01%	2292
2020 Q2	$113K	Hold	6,151	–	–	﹤0.01%	2308
2020 Q1	$96K	Hold	6,151	–	–	﹤0.01%	2261
2019 Q4	$132K	Buy	+6,151	New	+$127K	﹤0.01%	2318

Other funds holding RIGL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SEI Investments's RIGL Position: Q1 2026 in Review

SEI Investments increased its Rigel Pharmaceuticals (RIGL) stake by 13% in Q1 2026, buying an estimated $114K and bringing the position to 30,192 shares worth $816K. The position accounts for ﹤0.01% of the portfolio, ranked #2448.

SEI Investments first reported a position in RIGL in Q4 2019 and has held it in 8 quarters since. The position peaked at $1.7M in Q3 2025. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

SEI Investments held 30,192 shares of Rigel Pharmaceuticals worth $816K as of Q1 2026.
SEI Investments bought 3,399 Rigel Pharmaceuticals shares in Q1 2026, an estimated $114K.
Rigel Pharmaceuticals made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #2448 holding.
SEI Investments first reported a position in Rigel Pharmaceuticals in Q4 2019 and has held it in 8 quarters since.
SEI Investments's Rigel Pharmaceuticals position peaked at $1.7M in Q3 2025.
159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.